Cervical cancer (which the American Cancer Society says will occur in an estimated 9,710 women this year) is by far the most significant concern. However, high-risk types of HPV also have been linked to less-common cancers of the vagina (2,420 women), vulva (3,740), anus and, in men, penis (1,530). [Anal cancer is included in the numbers for vulvar cancer for women and penile cancer for men.

In one study conducted by the National Cancer Institute (NCI), 4 percent of women who were found through testing to have high-risk HPV developed advanced, pre-cancerous cervical disease (CIN 3) in the following three years. When watched for 10 years, about 7 percent of the women developed advanced cervical disease. However, if a woman happens to have high-risk HPV type 16 or 18, which can be determined by some laboratories, those percentages are higher.

Cervical cancer is primarily caused by the HPV virus (99.7%). So a vaccine stopping HPV would appear to stop cervical cancer. Among the vaccines under development, two of the companies are in Phase III clinical trials (Glaxo & Merck) and appear close to providing data to the FDA. These vaccines focus in on HPV types 16 and 18 which account for 70% of the cervical cancers.

Each state decides whether or not to require vaccinations for enrollment in childcare or school attendance.14 Although not binding, ACIP recommendations are followed closely by healthcare professionals and organizations; an ACIP recommendation usually determines whether a vaccine becomes the standard of care, whether an insurer will reimburse for it, and whether states will publicly fund it.

For most women, HPV infection clears up on its own. However, for some women infected with HPV, the virus can result in the development of abnormalities and precancerous cells. Cervical abnormalities can be detected by a pap smear test. Certain types of HPV, the ones that cause cervical cancer, are also referred to as ???high risk??? types.

Early cervical cancer may not cause noticeable signs or symptoms. Women should have yearly check-ups, including a Pap smear to check for abnormal cells in the cervix. One of the greatest risk factors is infection with HPV (human papillomavirus). A weakened immune system is also a risk factor for cervical cancer.

Certain strains of HPV that affect the genitals can actually cause the cervical cell changes that may lead to cervical cancer. Immunising women against these strains of HPV can protect women from contracting the viruses that cause most cervical cancer.

HPV is short for human papillomavirus. An HPV infection is usually harmless and temporary: most people with HPV will never know they are infected because the virus usually goes away on its own. There are many types of this common virus, and only a few “high-risk” types can lead to cervical cancer. These high-risk HPV types are spread through sexual contact. There are also “low-risk” types of HPV that can cause genital warts but do not cause cancer.

In Europe, cervical cancer is the second leading cause of cancer-related deaths among young women (between 15-44). In Europe 40 women die each day of cervical cancer. In the UK there are approximately 2,800 new cases of cervical cancer every year and about 1,100 deaths every year. This means in the UK, 21 women on average die each week from cervical cancer.

Some types of HPV cause common skin warts, such as those found on the hands and soles of the feet. These types of HPV do not cause genital warts.

The relationships between certain strains of HPV and cervical cancer have been understood for some years. The new HPV vaccine is the culmination of research conducted over the last decade. The vaccine is a breakthrough that can help to protect women from infection by certain strains of the HPV virus that are linked with 70% of cervical cancers.

Approximately 10 of the 30 identified genital HPV types can lead to the development of cervical cancer, although this is a rare occurrence. Research has shown that for 90% of infected women, cervical HPV infection cannot be found in two years. Although only a small proportion of women have persistent (ongoing) infection, persistent infection with a “high-risk” type of HPV is the main risk factor for cervical cancer.

your next annual physical, ask your physician to perform the ThinPrep Pap test and recommend it be sent to Centrex Clinical Laboratories, Inc., where you can count on the accuracy of the results. Centrex is now reporting pap smear results in the Bethesda System 2001. Physicians interested in the new reporting terminology are encouraged to contact our Technical Support or Cytology Department at 1.800.562.1550.

Associations that represent physicians often develop guidelines for what tests should be offered, to whom and how often. These guidelines help assure that doctors and nurses offer the best care to patients. The guidelines most often used by physicians for the prevention of cervical cancer are developed by the American College of Obstetricians and Gynecologists (ACOG), the American Cancer Society (ACS) and the American Society for Colposcopy and Cervical Pathology (ASCCP).

Yes! Our office is proud to offer the vaccine, Gardisil. This vaccine helps to protect against HPV that causes the most common types of cervical cancer and genital warts. It is given in a total of three series.

Most cervical cancers can be prevented. Pap tests are an effective way to detect problems. Once these problems are detected, treatment can stop these complications before they develop into invasive cervical cancer.

HPV is very common, but cervical cancer is not. It is estimated that at least 80 percent of women will acquire a genital HPV infection by the time they reach the age of 50. Both younger and older women are at risk of cervical cancer because of infection with oncogenic HPV. The body’s defense mechanisms clear most HPV infections without any risk of the infection progressing to cancer. But some women infected with oncogenic HPV types develop long-term, persistent infections.

Once an HPV “infection” occurs, one or more of the following three pathways may occur: Latent HPV infection—most people who get HPV do not have any detectable warts or other HPV disease and probably have HPV in very low numbers (perhaps 1 HPV per infected cell). Individuals with “latent” HPV are not contagious.

NO. More than 2000 clinical studies have been conducted on the use of LILT and in all of these studies no mutational effects have ever been observed resulting from therapy with wavelengths in the red or near-infrared ranges in the doses used by laser therapy.

The answer is no. No mutational effects have been observed resulting from light with wavelengths in the red or infra-red range and of doses used within LLLT. But what happens if I treat someone who has cancer and is unaware of it? Can the cancer's growth be stimulated? The effects of LLLT on cancer cells in vitro have been studied, and it was observed that they can be stimulated by laser light. However, with respect to a cancer in vivo, the situation is rather different.

Severe, long-standing GERD can damage the esophagus and cause a condition known as Barrett's esophagus wherein the normal lining of the esophagus is replaced by a lining more like that of the stomach or intestine. It is thought that this replacement may be an attempt by the body to protect itself from further injury by acid. The risk of esophageal cancer appears to increase significantly in patients with Barrett's esophagus. The only way to diagnose Barrett's esophagus is by endoscopy.

The functioning of all parts of the human body at all levels is governed and controlled by the genes. The genes can be thought of as a large and elegant software or information store, which controls the development of human body and its normal functioning. The genes are responsible for cell multiplication, cell growth and cell death. All cancers are caused by some abnormality in the genes.

The International Agency for Research on Cancer (IARC), the Department of Health and Human Services (DHHS), and the Environmental Protection Agency (EPA) have not reviewed tetryl to determine whether it is likely to cause cancer.

There are no known causes of prostate cancer. Approximately 10 % of prostate cancers are inherited but the remaining cases occur at random. A “prostate cancer gene” has not yet been identified. There are links between diets rich in saturated fats and an increased incidence of prostate cancer but this evidence is based on epidemiologic data and not based on data obtained from clinical practices.

Gallstones are the most common risk factor for gallbladder cancer. Between 75% and 90% of people with gallbladder cancer also have gallstones and an inflamed gallbladder. Gallbladder cancer is more likely to happen if your gallbladder has a single large gallstone than several small ones. Doctors believe that large gallstones grow over a long time, irritating the gallbladder wall and increasing the risk for gallbladder cancer.

Laser beam is very safe because laser medicine generally utilizes wavelengths above 632 nm (nanometer). Therefore the laser beam is not ionizing radiation (which can cause cancer) like X-rays, Gamma rays etc. Sunlight contains cancer causing wavelengths (below 320 nm), which is ultraviolet. There is no certain limit for penetration of laser light. It spreads in all directions and is absorbed in tissues. Light's intensity weakens the deeper from the target point it goes.

Most precancerous conditions of the cervix could be detected and treated before cancer develops if all women had pelvic exams and Pap tests regularly. This way, most invasive cancers could be prevented. Any invasive cancer that does occur would likely be found at an early, curable stage.